Nektar Therapeutics
Business: Pharma & Medical Devices | Pharmaceutical Companies
Recent News About Nektar Therapeutics
-
H-1B Insights: Employers in San Francisco Sun publication area file 9,062 petitions throughout 2024
Employers based in the San Francisco Sun publication area submitted 9,062 H-1B petitions during 2024, according to data provided by the U.S. Citizenship and Immigration Services via the H-1B Employer Data Hub.
-
16 San Francisco biopharma companies could be negatively impacted by Inflation Reduction Act drug provision
A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said the head of the Pasadena-based Pacific Research Institute (PRI).